Eary JF - Search Results

1

Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU 3rd, Eary JF. Schuetze SM, et al. Among authors: eary jf. Cancer. 2005 Jan 15;103(2):339-48. doi: 10.1002/cncr.20769. Cancer. 2005. PMID: 15578712 Free article.

2

Samarium-153-EDTMP biodistribution and dosimetry estimation.

Eary JF, Collins C, Stabin M, Vernon C, Petersdorf S, Baker M, Hartnett S, Ferency S, Addison SJ, Appelbaum F, et al. Eary JF, et al. J Nucl Med. 1993 Jul;34(7):1031-6. J Nucl Med. 1993. PMID: 7686217 Free article. Clinical Trial.

3

Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.

Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, Livingston RB, Gordon EE, Chapman CR, Appelbaum FR. Collins C, et al. Among authors: eary jf. J Nucl Med. 1993 Nov;34(11):1839-44. J Nucl Med. 1993. PMID: 8229221 Free article. Clinical Trial.

4

Tumor metabolic rates in sarcoma using FDG PET.

Eary JF, Mankoff DA. Eary JF, et al. J Nucl Med. 1998 Feb;39(2):250-4. J Nucl Med. 1998. PMID: 9476930 Free article.

5

Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.

Eary JF, Conrad EU, Bruckner JD, Folpe A, Hunt KJ, Mankoff DA, Howlett AT. Eary JF, et al. Clin Cancer Res. 1998 May;4(5):1215-20. Clin Cancer Res. 1998. PMID: 9607579

6

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.

Eubank WB, Mankoff DA, Schmiedl UP, Winter TC 3rd, Fisher ER, Olshen AB, Graham MM, Eary JF. Eubank WB, et al. Among authors: eary jf. AJR Am J Roentgenol. 1998 Oct;171(4):1103-10. doi: 10.2214/ajr.171.4.9763005. AJR Am J Roentgenol. 1998. PMID: 9763005

7

2-[C-11]thymidine imaging of malignant brain tumors.

Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, O'Sullivan F, Krohn KA. Eary JF, et al. Cancer Res. 1999 Feb 1;59(3):615-21. Cancer Res. 1999. PMID: 9973209 Clinical Trial.

8

(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.

Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. Folpe AL, et al. Among authors: eary jf. Clin Cancer Res. 2000 Apr;6(4):1279-87. Clin Cancer Res. 2000. PMID: 10778952

9

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell KD, Yeung RS, Moe RE. Nason KS, et al. Among authors: eary jf. Cancer. 2000 Dec 1;89(11):2187-94. Cancer. 2000. PMID: 11147588 Clinical Trial.

10

Positron Emission Tomography in Grading Soft Tissue Sarcomas.

Eary JF, Conrad EU. Eary JF, et al. Semin Musculoskelet Radiol. 1999;3(2):135-138. doi: 10.1055/s-2008-1080057. Semin Musculoskelet Radiol. 1999. PMID: 11387131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters